Metabolism of Ether Phospholipids and Analogs in Neoplastic Cells

Overview

Journal Lipids

Specialty Biochemistry

Date 1987 Nov 1

PMID 3444378

Citations 15

Authors

E A Fleer

C Unger

D J Kim

H Eibl

Affiliations

Soon will be listed here.

Abstract

The ether phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (OM-GPC) is known to be a potent inhibitor of cell growth. Metabolic studies in both Raji and L1210 leukemic cells on OM-GPC, 3H-labeled in the methyl groups of the choline moiety, showed a (diacyl)-phosphatidylcholine as the only labeled metabolite. Since the formation of radiolabeled (diacyl)-phosphatidylcholine showed a direct correlation with cell death, we tested other lipid analogs. One of these compounds, hexadecylphosphocholine (He-PC), which was 3H-labeled in the methyl-choline groups, showed a formation of labeled (diacyl)-phosphatidylcholine similar to that found with OM-GPC. Again, there was a direct linear correlation between the formation of the labeled product and cell death. He-PC was found to be a potent cell toxin in in vitro experiments on cell cultures. However, analogs with an elongated phosphor to trimethylammonium distance showed no toxicity towards the cells in in vitro experiments. From the data, we conclude that the ether phospholipids are substrates for a phospholipase C or related enzyme. This substrate property may be responsible for the toxicity of the compounds in neoplastic cells.

Citing Articles

Micellar Curcumin Substantially Increases the Antineoplastic Activity of the Alkylphosphocholine Erufosine against TWIST1 Positive Cutaneous T Cell Lymphoma Cell Lines.

Trochopoulos A, Ilieva Y, Kroumov A, Dimitrova L, Tibi I, Philipov S Pharmaceutics. 2022; 14(12).

PMID: 36559182 PMC: 9781439. DOI: 10.3390/pharmaceutics14122688.

Perifosine , an oral, anti-cancer agent and inhibitor of the Akt pathway: mechanistic actions, pharmacodynamics, pharmacokinetics, and clinical activity.

Richardson P, Eng C, Kolesar J, Hideshima T, Anderson K Expert Opin Drug Metab Toxicol. 2012; 8(5):623-33.

PMID: 22512706 PMC: 4467022. DOI: 10.1517/17425255.2012.681376.

Phase II study of perifosine in previously untreated patients with metastatic melanoma.

Ernst D, Eisenhauer E, Wainman N, Davis M, Lohmann R, Baetz T Invest New Drugs. 2005; 23(6):569-75.

PMID: 16034524 DOI: 10.1007/s10637-005-1157-4.

Effects of miltefosine and other alkylphosphocholines on human intestinal parasite Entamoeba histolytica.

Seifert K, Duchene M, Wernsdorfer W, Kollaritsch H, Scheiner O, WIEDERMANN G Antimicrob Agents Chemother. 2001; 45(5):1505-10.

PMID: 11302818 PMC: 90496. DOI: 10.1128/AAC.45.5.1505-1510.2001.

Alkylphosphocholines: a new class of membrane-active anticancer agents.

Hilgard P, Klenner T, Stekar J, Unger C Cancer Chemother Pharmacol. 1993; 32(2):90-5.

PMID: 8485813 DOI: 10.1007/BF00685608.

References

Soodsma J, Piantadosi C, Snyder F . Partial characterization of the alkylglycerol cleavage enzyme system of rat liver. J Biol Chem. 1972; 247(12):3923-9. View

Unger C, Eibl H, von Heyden H, Nagel G . New assay for the O-alkyl cleavage enzyme with alkyl-lysophospholipids as substrates. Cancer Res. 1985; 45(2):616-8. View

Storme G, Berdel W, van Blitterswijk W, Bruyneel E, De Bruyne G, Mareel M . Antiinvasive effect of racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine on MO4 mouse fibrosarcoma cells in vitro. Cancer Res. 1985; 45(1):351-7. View

van Blitterswijk W, van der Bend R, Kramer I, Verhoeven A, Hilkmann H, de Widt J . A metabolite of an antineoplastic ether phospholipid may inhibit transmembrane signalling via protein kinase C. Lipids. 1987; 22(11):842-6. DOI: 10.1007/BF02535541. View

Eibl H, Westphal O . [14C-labelled lecithin and lysolecithin]. Justus Liebigs Ann Chem. 1967; 709:231-3. DOI: 10.1002/jlac.19677090125. View

Berdel W, Greiner E, Fink U, Zanker K, Stavrou D, Trappe A . Cytotoxic effects of alkyl-lysophospholipids in human brain tumor cells. Oncology. 1984; 41(2):140-5. DOI: 10.1159/000225809. View

Berdel W, Schick H, Fink U, Reichert A, Ulm K, Rastetter J . Cytotoxicity of the alkyl-linked lipoidal amine 4-aminomethyl-1-[2,3-(di-n-decyloxy)-n-propyl]-4-phenylpiperidine (CP-46,665) in cells from human tumors and leukemias. Cancer Res. 1985; 45(3):1206-13. View

Voelker D, Kennedy E . Phospholipid exchange protein-dependent synthesis of sphingomyelin. Methods Enzymol. 1983; 98:596-8. DOI: 10.1016/0076-6879(83)98188-0. View

BLIGH E, Dyer W . A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959; 37(8):911-7. DOI: 10.1139/o59-099. View

10.

Lee T, Blank M, Fitzgerald V, Snyder F . Substrate specificity in the biocleavage of the O-alkyl bond: 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid) and its metabolites. Arch Biochem Biophys. 1981; 208(2):353-7. DOI: 10.1016/0003-9861(81)90519-1. View

11.

Tidwell T, Guzman G, VOGLER W . The effects of alkyl-lysophospholipids on leukemic cell lines. I. Differential action on two human leukemic cell lines, HL60 and K562. Blood. 1981; 57(4):794-7. View

12.

Berdel W . Antineoplastic activity of synthetic lysophospholipid analogs. Blut. 1982; 44(2):71-8. DOI: 10.1007/BF00320092. View

13.

Helfman D, Barnes K, KINKADE Jr J, VOGLER W, Shoji M, Kuo J . Phospholipid-sensitive Ca2+-dependent protein phosphorylation system in various types of leukemic cells from human patients and in human leukemic cell lines HL60 and K562, and its inhibition by alkyl-lysophospholipid. Cancer Res. 1983; 43(6):2955-61. View